个人简介
2013年毕业于暨南大学，获博士学位；2013-2016年，在国家纳米科学中心从事博士后研究工作；2017年至今，任职于广州医科大学药学院分子与临床药理研究所。主要从事纳米生物材料与药物递送、生物可降解材料和基因编辑等工作。先后在Angewandte Chemie International Edition，NPG Asia Materials，Advanced Science，Biomaterials，Carbon和Journal of Materials Chemistry B等国际知名杂志以第一（包括共一）作者发表学术论文。目前承担有国家自然科学基金青年项目。
近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
(1) L. Zhang#, P. Wang#, Q. Feng, N. Wang, Z. Chen, Y. Huang, W. Zheng, X. Jiang. Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy. NPG Asia Mater. 2017, 9, e441. (2) L. Zhang, X. Yang, Y. Li, W. Zheng, X. Jiang. Hollow carbon nanospheres as a versatile platform for co-delivery of siRNA and chemotherapeutics. Carbon 2017, 121, 79-89. (3) L. Zhang, P. Wang, W. Zheng, X. Jiang. Hollow carbon nanospheres for targeted delivery of chemotherapeutics in breast cancer therapy. J. Mater. Chem. B, 2017, 5, 6601-6607. (4) L. Zhang, W. Zheng, R. Tang, N. Wang, W. Zhang, X. Jiang. Gene regulation with carbon-based siRNA conjugates for cancer therapy. Biomaterials 2016, 104, 269-278. (5) L. Zhang, C. Wu, J. Huang, X. Peng, P. Chen, S. Tang. Synthesis and characterization of a degradable composite agarose/HA hydrogel. Carbohyd. Polym. 2012, 88, 1445-1452. (6) P. Wang#, L. Zhang# (Co-first), W. Zheng, L. Cong, Z. Guo, Y. Xie, L Wang, R. Tang, Q. Feng, Yoh Hamada, K. Gonda, Z. Hu, X. Wu, X. Jiang. Thermo-triggered release of CRISPR-Cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy. Angew. Chem. Int. Ed. 2018, 57, 1491-1496. (7) P. Wang#, L. Zhang# (Co-first),Y. Xie, N. Wang, R. Tang, W. Zheng, X. Jiang. Genome editing for cancer therapy: Delivery of Cas9 protein/sgRNA plasmid via a gold nanocluster/lipid core-shell nanocarrier. Adv. Sci. 2017, 4, 1700175.
京公网安备 11010802027423号